Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Nihon Kohden Corporation ( (JP:6849) ).
Nihon Kohden has partially revised its previously announced Career Change Support Program and Next Career Support Program for employees, which target staff in Japan, including those engaged in its Abbott business and those meeting certain age and other requirements. The company has extended the application period for the Career Change Support Program to February 25, 2026, and postponed the retirement date for applicants to March 31, 2026, in order to secure sufficient time to transition operations related to its Abbott business. As of the end of December 2025, 147 employees had applied across both programs, and Nihon Kohden has recorded approximately 2.4 billion yen in extra early retirement payments as extraordinary losses in the third quarter of FY2025, already reflected in its consolidated earnings forecast, indicating a material but managed financial impact as it restructures its workforce.
The most recent analyst rating on (JP:6849) stock is a Buy with a Yen2015.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation is a Japan-based medical device manufacturer listed on the Prime Market of the Tokyo Stock Exchange. The company develops and sells medical electronics such as patient monitors, diagnostic equipment, and related systems, with a focus on hospital and clinical markets in Japan and overseas.
Average Trading Volume: 618,093
Technical Sentiment Signal: Buy
Current Market Cap: Yen285.9B
For a thorough assessment of 6849 stock, go to TipRanks’ Stock Analysis page.